Business Context and Reporting Period
This Form 8-K was filed by NanoVibronix, Inc. on October 11, 2017. The registrant is an emerging growth company incorporated in Delaware with principal executive offices in Nesher, Israel. The filing reports on corporate governance changes and a modification to a services agreement effective October 11, 2017.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial data disclosed relates to a change in a contractual payment obligation:
- Services Agreement Payment: Monthly payment to Multigon Industries, Inc. increased from $4,000 to $7,000.
- Commission Structure: Per-unit commission on sales of the PainShield product in the United States was discontinued.
Material Changes
The filing details two material changes effective October 11, 2017:
- Board Resignation: William Stern, Ph.D., resigned as a member of the Board of Directors. The resignation was effective immediately and was not connected to any disagreement regarding the Company's operations, policies, or practices. Dr. Stern continues to serve as President of the Company.
- Contract Modification: The Company modified its Services Agreement with Multigon Industries, Inc. (presided over by Dr. Stern). The modification increased the fixed monthly fee and eliminated variable per-unit commissions on U.S. PainShield sales.
Outlook, Risks, and Management Commentary
The filing does not contain forward-looking guidance, financial outlook, or general risk factors. Management commentary is limited to the explanation that Dr. Stern's board resignation was not due to any disagreement with the Company. The change in the services agreement reflects a shift from a variable commission model to a higher fixed-fee model for administrative and logistical services provided by Multigon.
Key Facts for Investor Verification
- Verify the impact of the increased fixed monthly payment ($7,000) versus the discontinued per-unit commission on the Company's cost structure and gross margins.
- Confirm the composition of the Board of Directors following Dr. Stern's resignation and whether a replacement has been appointed.
- Review the full text of the modified Services Agreement to understand the scope of services provided by Multigon Industries, Inc.
- Assess the potential conflict of interest implications given Dr. Stern's dual role as Company President and President of Multigon.